1976. -A compartmental model is presented to account for transient and steady-state changes in blood glucose concentration which result from transit through the forearm and hand in man. This model permits the interconversion of arterial and venous data and the derivation of arterial equivalent total body glucose models from venous data. Data were obtained from subjects in the basal state following a pulse injection of tracer. An artery, an antecubital vein, and a dorsal vein of a heated hand (68°C environment)
were sampled. Blood transit time is shorter (0.3 vs. 1.0 min) and irreversible glucose loss is reduced (1.9 vs. 2.9%) in the heated hand preparation when compared to the antecubital vein preparation. Because of the smaller correction required and the smaller variation among individuals when heated hand rather than antecubital vein data are obtained, we suggest that for analysis of whole-body kinetics such data should be used along with the compartmental model correction when arterial data cannot be obtained.
metabolism;
compartments; models; transit time ARTERIAL KINETIC DATA on the in vivo distribution and metabolism of a substance represent an average of the processes occurring in the several tissues comprising the total body. Venous data, though more easily obtainable in man, reflect metabolism in the particular organ drained in addition to that in the body as a whole and thus yield a distorted picture of total body kinetics. The differences which can be expected between the pattern of events seen in an artery and that seen in a vein have been documented and discussed many times (e.g., 2, 4, 10, 14, 21, 23-25). These differences are due to 1) the transit times of substances through the circulatory paths between the two sampling sites, and2) the loss of substances to the intervening tissues.
In this paper we discuss the sampling site problem as it applies to the distribution volume and kinetics of glucose, in particular to data collected from the forearm and hand in man. We have approached the problem in two ways. First, a mathematical relation is developed to describe quantitatively the differences between glucose kinetics seen in an artery and those seen in a vein.
Second, an experimental procedure is proposed which minimizes the differences between data collected from arterial and venous sites. The combination of these two approaches provides a simple, reliable procedure for estimating arterial glucose responses from observed venous data.
EXPERIMENTAL PROCEDURES Patient Selection
The subjects were healthy male volunteers. All had negative family histories of diabetes and normal oral glucose tolerance tests using age adjusted criteria (1). All subjects were consuming a weight-maintaining diet estimated to include at least 200 g carbohydrate and were taking no medications. The studies were performed in the morning following an overnight fast. All subjects were advised of the nature, scientific goals, and possible hazards of the studies prior to consenting to participate.
Experimental Protocols
Three-vessel studies. This protocol involved the use of [14C]glucose to study glucose kinetics under basal, steady-state conditions, and served as the basis for the model. The subjects were all young (ages 20-33 yr) and within 20% of their desirable body weight.' Blood samples were collected from catheters (Bardic 1617 R, 8 in., C. R. Bard, Inc., Murray Hill, N.J.) placed in a brachial artery, an antecubital vein, and a dorsal hand vein. The artery and the hand vein were located in the same arm. The antecubital vein was located in the opposite arm and was the largest, most accessible one present. The catheters in the artery and antecubital vein were passed toward the heart (proximally). Thus, this was not the deep vein catheterization of the traditional "forearm technique." This vein will be referred to in the paper as the forearm vein. The hand vein catheter was passed in a retrograde manner to the most distal site from which adequate sampling was possible. The catheterized hand was then placed in a warming chamber (air at 68°C) for ' Desirable weight was taken as the midpoint of the weight range for males of medium frame as given in the 1959 Metropolitan  Life  Insurance  Company  table of desirable  weights. the duration of the study. A control period of at least 25 min was used to allow blood flow in the hand to adjust to the increased temperature. At the end of the control period 10 PC1 of sterile n[lJ"C]glucose (Amersham/ Searle Corp., Arlington Heights, Ill.) in 18 ml of physiologic saline was injected rapidly (12-20 s) into a separate antecubital vein. Blood samples were collected simultaneously from the three vessels over a 20-s period with the midpoints of the collections immediately prior to and 2, 3, 4, 6, 8, 10, 12.5, 15, 20, 30, 40, 60, 100, 140, and 180 min after the start of the injection. Between collections catheters were kept patent by a slow infusion of physiologic saline which was stopped 1 min before each collection. Plasma samples were analyzed for labeled (tracer) glucose and unlabeled (tracee) glucose using the procedures described below.
To test the applicability of the model to nonsteady states, previously available data from intravenous glucose tolerance tests (IVGTT) and hyperglycemic clamp studies were utilized.
Intravenous glucose tolerance tests. The study population was five older men (ages 52-82 yr). Glucose (0.375 g/ kg body wt) was given over a 5-min period with zero time taken to be the start of the injection. Simultaneous blood samples were obtained from the brachial artery and an antecubital vein at 1-min intervals for the first 10 min and then at lo-min intervals through 60 min, with a final sample at 80 min. Blood samples were analyzed for glucose.
Hyperglycemic cZamp studies. One set of studies using the forearm sampling technique described above was carried out in five young men (ages 20-22 yr). A second set of clamp studies was performed on eight men (ages 24-59 yr) using the heated hand vein preparation. Arterial blood glucose concentration was raised rapidly to a predetermined level (mean of 280 mg/dl in the forearm studies and 220 mg/dl in the heated hand vein studies) and maintained within 10% of this level by a variable, exogenous infusion of glucose. Simultaneous samples were obtained from the brachial artery and either the forearm vein or the heated hand vein prior to the start of the glucose infusion, at 2-min intervals for the first 10 min following the start of the infusion, then at 5-min intervals for the duration of the study (70 min for the forearm studies and 120 min for the heated hand studies). Blood samples were analyzed for glucose. Under conditions of basal, steady-state glucose metabolism the glucose concentration in the artery is consistently higher than that in the heated hand vein or the forearm vein. When the basal glucose concentrations for all 13 heated hand studies are averaged the arteriovenous difference is 0.017 _ + 0 002 mg/ml (+SEM), while for the 15 forearm studies the difference is 0.031 t 0.006 mg/ml (*SEM).
Chemical Analyses
The standard deviations for these two sets of data (0.009 and 0.021 mglml, respectively) also indicate a greater variation among individuals for the forearm measurements than for the heated hand measurements.
The data for each type of study are given in Figs. l-3. Throughout the three vessel studies glucose metabolism remained in the basal steady state. The tracer glucose data from these studies ( Fig. 1 ) have been corrected to eliminate recycled glucose which averaged 1.9% at 60 min and increased to approximately 12% at 180 min. At all times the tracer glucose activity (dpm per ml plasma water) in the heated hand vein followed that in the artery more closely than did the tracer activity in the forearm vein. The differences were most marked at the earliest times. The mean forearm vein tracer activity was only about two-thirds of the simultaneously obtained mean arterial value at 2 min while the mean heated hand vein activity was 88% of the arterial value at that time.
Similar results were obtained in the other two types of study in which tracee glucose was measured. For the intravenous glucose tolerance tests the average glucose concentration in forearm vein was 65% of that in the artery at the end of the 5-min glucose infusion. However, by 30 min the difference had reached 3%, the difference seen in the basal state at the start of the studies. Figure 2 illustrates the range of variation of the observed forearm venous responses in our IVGTT studies. In the hyperglycemic clamp studies (Fig. 3 100. I* The purpose of the modeling was to derive functions to generate the observed venous responses produced by changes in the concentration of a substance in an artery supplying the forearm in man. For a linear, constant parameter system such a function is known as a weighting function, w(t), and is uniquely defined by the convolution integral 11 and 12) with an irreversible loss from compartment Mean population data were used to determine the 12. This model, however, predicted too low a value for model parameter values. Initially data from each type the basal venous glucose levels, implying that some of the glucose lost irreversibly from compartment 12 had --L,* *h*,,, *-h,,, * G -GdIL,,l * L3.12 * Cl1 + ~O*ll * to return, but at a rate too slow to be seen with the (L,: :Fi 13,12) * (C,, -C,)), where C6 is the arterial glucose concentration and C,, is the venous glucose concentration.
conriguration 01 tne compartments is aroi--gurations are equally acceptable (6). n data were used to determine the .meter values. Initially data from each type of study (forearm vein and heated hand vein) were fit independently. However, since the major difference between the two sets of parameters was in the value for L,, ,, the data were refit subject to the hypothesis that it be'the only parameter to differ between the two studies (5). The other th ree parameters L,, 19 L* 1,127 and LL12) each were constrained to adjust to a common value for the two sets of data.
To gain greater confidence in the estimates of uncertainty for the critical parameters we applied a nonlinear error estimation technique to the constrained model. Each parameter in turn was systematically set to a number of fixed values over a wide range about its mean, and for each fixed value a least-squares fit of the data was obtained by allowing all other parameters to adjust. This procedure gave the best estimate for the value of each parameter and an estimate of the range through which it could vary and still give an acceptable fit of the data. For all parameters of the model the estimate of uncertainty was 30% or less. The param.eter values for the model are given in Table 1 Once derived, the appropriate weighting function can be used along with venous concentration data to obtain (by deconvolution) the arterial concentration curve which .would produce the observed venous response. The arterial concentration curve can then be analyzed in terms of a whole-body model for glucose kinetics such as was previously published by this group for measured arterial data (15). The entire sequence of calculations can be carried out directly by coupling the whole-body model to the weighting function model as shown in Fig. 4 . Given a known exogenous glucose input, the weighting function model and venous data, the parameters of the whole-body glucose model can be adjusted to give a "best" fit of the venous data. The three-compartment whole-body glucose model so derived may be considered an "arterial equivalent" whole-body model, comparable to one which would have been obtained had arterial data been available directly. The response obtained for compartment 6 is the predicted arterial glucose concentration curve. Although the weighting function model was derived from tracer data for the basal state, we felt it of interest to see how well it might apply to data obtained from the IVGTT and hyperglycemic clamp studies. In doing this, we chose to fit these data subject to the constraint that the parameter values be constant and remain as close to those of the three-vessel model as possible. The fits obtained are given in Figs. 2 and 3 , the parameter values in Table 2 . The weighting functions derived from each set of data can be visualized by using each to generate the venous response to a step increase in the arterial glucose level (Fig. 5, A and B ) . In all cases the response measured in the heated hand vein is closer to that in the artery than is the response in the forearm vein during the transient as well as the steady state phase. In addition, the range of individual responses for the three-vessel study is less for the heated hand vein than for the forearm vein.
DISCUSSION
It is our assumption in the present study that the best kinetic data for the analysis of total body metabolism are arterial data. The distortion of patterns in arterial data following passage of the blood through a particular organ are the result of the transit time distribution spectrum imposed on incoming material by the organ. We have represented this transit time spectrum for the forearm by a deterministic model composed of three compartments. Despite the fact that L,, 13 could not be determined from our data a slow exchange compartment must exist in the organ to explain the difference between transient tracer and steady-state basal glucose data. Blood flow (F), volume (V), and mean transit time (7) for an organ are related by the equation F = V/T. Since neither F nor V was measured in our studies, absolute flows and volumes cannot be calculated. The same holds for masses and transports of substances in the blood. However, the model does permit the calculation of relative masses (Mi) for compartments 11, 12, and 13. In the case of glucose the ratio of M,,/M,,, and thus the plasma equivalent volume ratio (interstitial:vascular), is approximately 4. The calculated interstitial to vascular glucose mass ratio is further increased by the contribution of compartment 13. This mass ratio for the forearm is considerably higher than the estimated interstitial to blood water volume ratio for the body as a whole (approx. 2.). This suggests a relatively larger interstitial space for the forearm compared to the body as a whole, or a higher extravascular glucose concentration, or both. It should be realized, however, that the extravascular to vascular mass ratio derived from these experiments reflects predominantly the tissues immediately surrounding the particular forearm or hand vein sampled and may not be typical of the mean for the entire forearm or the body as a whole.
Blood transit times derived from our analysis (l/L,,,,) are comparable to previously published results. For the forearm the transit time is 1.0 min. This compares to an average of 1.39 min for all body tissues as calculated by Waterhouse and Keilson (24) and 1.7 min as calculated from the data of Andres et al. (2) . It is difficult for us to calculate a mean transit time for glucose because our data are insufficient to determine the slow component of the weighting function (equivalent to compartment 13 of our model). However, for the forearm vein about 50% of the glucose entering has a mean transit time of 0.23 min and an additional 45% has a mean transit time of 3.4 min. The remaining 5% has a transit time greater than 5 min. It should be pointed out that a large mean transit time for the remaining 5% would greatly affect the total mean transit time for glucose. In the heated hand the blood mean transit time is 0.31 min-only about one-third that of the forearm. This is undoubtedly due to more rapid blood flow and shorter pathways.
The irreversible glucose loss, expressed as a fraction of glucose entering the organ (Table 2) , is a net loss. Its estimated value depends on the measured steady-state arterial and venous glucose concentrations and is inde-pendent of the mean transit time for glucose. The loss is primarily due to tissue uptake but other processes may contribute to it. For the forearm the fractional loss in the basal state is about 3% ( However, when the forearm vein is used the fractional loss rate increases greatly in response to prolonged hyperglycemia-probably due to increased tissue uptake as a result of elevated insulin levels.
The weighting functions used to describe the arteriovenous differences assume that the parameters of the system remain constant throughout the study. If the parameters are changing with time, the values derived for the model will reflect averages over the duration of the study. The assumption that the parameters of the weighting function are constant over time is strictly true only for the three-vessel studies in which the basal state was not disturbed. Transitory changes in insulin levels occurring during the IVGTT studies have a transitory effect on some of the parameters of the forearm model. Still, the overall effect is not sufficient to require parameter values different from those obtained from the three-vessel studies (Table 2 ). For the hyperglycemic clamp studies the insulin effects are greater both in magnitude and in duration. It is not surprising, therefore, that some of the parameter values are quite different. It may be noted, however, that the assumption of constant parameters over time is less critical for the heated hand studies since less glucose diffuses out of the vascular space in these studies than in the forearm studies. Although weighting functions and convolution integrals are not applicable to the proper analysis of nonlinear transient states, the compartmental approach can be extended to such cases by incorporating directly into the model the nonlinear features of the nonsteadystate system. However, this is beyond the scope of the present study.
Variations among individuals are relatively large when using forearm venous samples ( Fig. 2 and 5) . As a result, the use of a population mean weighting function for a particular individual may lead to a poor prediction of the arterial concentration curve for that individual. A more accurate prediction can be obtained using the heated hand vein technique since individual variations are smaller (Fig. 5) .
It is of interest to compare the parameters of the whole-body glucose model derived from arterial data with ones derived from venous data. Figure 6 represents TABLE 3. Parameters of whole-body glucose models 571 theoretically derived concentration curves under basal conditions for artery and forearm vein using our models. The arterial curve is a monotonically decreasing function with an intercept at t = 0 defined by the chosen initial space of distribution (blood water). For the venous curve the intercept at t = 0 is 0. It takes 5-10 min for the forearm venous curve to reach a value comparable to that of the artery. If one chose to build a glucose model using the venous data and constrained the initial space of distribution to be equal to that for the arterial model, the approximated curve would have an initial slope which would greatly depend on the earliest data points. As can be seen from Fig. 6 , venous sampling starting at 2 min yields an accelerated initial slope and hence more rapid rate constants between the fast compartments of the whole-body model (Table 3) . Differences can be seen in the values of several of the parameters of the whole-body model. However, the differences are much smaller for the heated hand model than for the forearm vein model.
One of the motivations for this study was to understand the wide variation in the total nlasma eauivalent 
